AddressWhat we can offer you (for eligible employees)…
- Accrued Day Off (ADO) (Full Time only),
- Opportunity for extra tax savings through Salary Packaging,
- Novated Leasing,
- Access to our Employee Assistance Program (EAP) for staff and family members,
- Fitness Passport,
- Great education opportunities through Sydney Education,
About working for SLHD
This is a Category A position. To be employed by NSW Health you are required to provide evidence of vaccination to comply with the NSW Health Occupational Assessment, Screening & Vaccination against Specified Infectious Diseases Policy (PD2023_022)
All NSW Health workers are required to have completed a primary course (2 doses) of a Therapeutic Goods Administration (TGA) approved or recognised COVID-19 vaccine (except for the Janssen COVID-19 vaccine which is approved by the TGA as a single dose primary course). New applicants must have completed the vaccination course prior to commencement with NSW Health, or provide an Australian Immunisation Register (AIR) Immunisation History Statement certifying the worker cannot have any approved COVID-19 vaccines available in NSW. A NSW Health agency may require further information about the medical contraindication (including but not limited to an Immunisation Medical Exemption form – IM011 form).
Acceptable proof of vaccination is the Australian Immunisation Register (AIR) Immunisation History Statement or AIR COVID-19 Digital Certificate. Booster doses are highly recommended for all health care workers who have completed the primary course of COVID-19 vaccinations.
SLHD is an equal opportunity employer committed to providing a working environment that embraces and values diversity and inclusion. Aboriginal and Torres Strait Islander people and people with disability are encouraged to apply for all internal and externally advertised positions. If you require assistance, please advise the contact person at the time of your application.
To further connect with us, check us out on LinkedIn
Applications Close: 27 February 2024
